Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$7.51 n/a | n/a%
10/24/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 12.02M 1.48M 803.00K 13.51M
Cost of Sales 1.10M 0.00 0.00 0.00
Gross Operating Profit 10.92M 1.48M 803.00K 13.51M
Selling, General, and Administrative Expenses 55.59M 20.13M 7.93M 5.08M
Research & Development 17.24M 23.52M 30.63M 35.15M
Operating Income before D & A (EBITDA) -61.92M -42.17M -37.75M -26.72M
Depreciation & Amortization 3.78M 1.20M 1.10M 1.46M
Interest Income 299.00K 120.00K 31.00K 107.00K
Other Income - Net -22.80M -660.00K 117.00K 542.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -88.20M -43.91M -38.70M -27.53M
Interest Expense 7.85M 3.58M 1.87M 12.39M
Pre-Tax Income -96.05M -47.48M -40.57M -39.92M
Income Taxes 0.00 0.00 -16.24M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -92.27M -46.28M -23.22M -38.46M
Net Income From Discontinued Operations 0.00 0.00 77.04M 0.00
Net Income From Total Operations -92.27M -46.28M 53.82M -38.46M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -92.27M -46.28M 53.82M -38.46M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-92.27M -46.28M -23.22M -38.46M
Preferred Dividends
Net Income Available To Common -92.27M -47.43M -26.66M -41.89M
Basic EPS from Continuing Ops. -2.90 -2.72 -1.68 0.00
Basic EPS from Discontinued Ops. 0.00 0.00 5.56 0.00
Basic EPS from Total Operations -2.90 -2.72 3.88 0.00
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.90 -2.72 3.88 0.00
Basic Normalized Net Income/Share -2.90 -2.72 -1.68 n.a.
EPS fr Continuing Ops. -2.90 -2.72 -1.68 0.00
EPS fr Discontinued Ops 0.00 0.00 5.56 0.00
EPS fr Total Ops. -2.90 -2.72 3.88 0.00
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.90 -2.72 3.88 0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.90 -2.72 -1.68 n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter